109 related articles for article (PubMed ID: 33195408)
1. Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode.
Jiawei Z; Min M; Yingru X; Xin Z; Danting L; Yafeng L; Jun X; Wangfa H; Lijun Z; Jing W; Dong H
Front Mol Biosci; 2020; 7():561456. PubMed ID: 33195408
[TBL] [Abstract][Full Text] [Related]
2. A DNA Replication Stress-Based Prognostic Model for Lung Adenocarcinoma.
Shi S; Wen G; Lei C; Chang J; Yin X; Liu X; Huang S
Acta Naturae; 2023; 15(3):100-110. PubMed ID: 37908773
[TBL] [Abstract][Full Text] [Related]
3. Identification of lung adenocarcinoma specific dysregulated genes with diagnostic and prognostic value across 27 TCGA cancer types.
Shang J; Song Q; Yang Z; Li D; Chen W; Luo L; Wang Y; Yang J; Li S
Oncotarget; 2017 Oct; 8(50):87292-87306. PubMed ID: 29152081
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive landscape of junctional genes and their association with overall survival of patients with lung adenocarcinoma.
Xie B; Wu T; Hong D; Lu Z
Front Mol Biosci; 2024; 11():1380384. PubMed ID: 38841188
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and prognosis of pancreatic cancer with immunoglobulin heavy constant delta blood marker.
Chen Q; Guo Q; Wang D; Zhu S; Wu D; Wang Z; Lu Y
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12977-12992. PubMed ID: 37466798
[TBL] [Abstract][Full Text] [Related]
6. Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li J; Xiao Y
Biomed Res Int; 2020; 2020():8896511. PubMed ID: 33195699
[TBL] [Abstract][Full Text] [Related]
7. Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma.
Wu L; Quan W; Luo Q; Pan Y; Peng D; Zhang G
Front Mol Biosci; 2020; 7():567950. PubMed ID: 33195412
[TBL] [Abstract][Full Text] [Related]
8. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
Li C; Long Q; Zhang D; Li J; Zhang X
BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma.
Zhang Y; Zhang X; Lv X; Zhang M; Gao X; Liu J; Xu Y; Fang Z; Chen W
Biomed Res Int; 2020; 2020():1836542. PubMed ID: 33195688
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma.
He L; Chen J; Xu F; Li J; Li J
Mol Ther Oncolytics; 2020 Dec; 19():265-277. PubMed ID: 33209981
[TBL] [Abstract][Full Text] [Related]
11. SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma.
Zhao J; Cheng M; Gai J; Zhang R; Du T; Li Q
Front Genet; 2020; 11():588499. PubMed ID: 33244319
[TBL] [Abstract][Full Text] [Related]
12. GJA1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Colorectal Cancer.
Hu W; Li S; Zhang S; Xie B; Zheng M; Sun J; Yang X; Zang L
Cancer Manag Res; 2020; 12():11649-11661. PubMed ID: 33235496
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer.
Yang L; Cui Y; Huang T; Sun X; Wang Y
Onco Targets Ther; 2020; 13():11669-11688. PubMed ID: 33235459
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis identification of key pathways and interaction network of differential gene expressions during osteogenic differentiation.
Khodabandehloo F; Taleahmad S; Aflatoonian R; Rajaei F; Zandieh Z; Nassiri-Asl M; Eslaminejad MB
Hum Genomics; 2020 Nov; 14(1):43. PubMed ID: 33234152
[TBL] [Abstract][Full Text] [Related]
15. A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm.
Xu S; Zhou J; Liu K; Chen Z; He Z
Biomed Res Int; 2020; 2020():9124792. PubMed ID: 33224985
[TBL] [Abstract][Full Text] [Related]
16. Identification of Genetic Biomarkers for Diagnosis of Myocardial Infarction Compared with Angina Patients.
Zhang Y; Tian C; Liu X; Zhang H
Cardiovasc Ther; 2020; 2020():8535314. PubMed ID: 33224271
[TBL] [Abstract][Full Text] [Related]
17. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma.
Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T
Aging (Albany NY); 2020 Nov; 12(22):23165-23186. PubMed ID: 33221754
[TBL] [Abstract][Full Text] [Related]
18. AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: Evidence from integrated analysis.
Zheng L; Li S; Zheng X; Guo R; Qu W
Int Immunopharmacol; 2021 Jan; 90():107185. PubMed ID: 33218938
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
[TBL] [Abstract][Full Text] [Related]
20. Expression and Bioinformatics-Based Functional Analysis of UAP1 in Lung Adenocarcinoma.
Wang X; Chen X; Liu H
Cancer Manag Res; 2020; 12():12111-12121. PubMed ID: 33269005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
